Skip to main content
. 2015 Sep 17;197(20):3255–3264. doi: 10.1128/JB.00547-15

TABLE 4.

Effects of G288D mutation in the wild-type and F610A backgrounds on MICs of inhibitors

AcrB protein or substitution(s)a MIC (μg/ml)b
Ery Nov Min Nal Cip SDS
AcrB-WT 128 128 1 4 0.032 800
F610A 4 16 0.25 1–2 0.008 400
G288D 64 64 0.5 4 0.032 400
F610A, G288D 64 64 1 4 0.032 800
a

The G288D substitution involved changing the GGT codon to GAT.

b

Ery, erythromycin; Nov, novobiocin; Min, minocycline; Nal, nalidixic acid; Cip, ciprofloxacin; SDS, sodium dodecyl sulfate.